Literature DB >> 9728958

Atrial fibrillation and cognitive function: case-control study.

J E O'Connell1, C S Gray, J M French, I H Robertson.   

Abstract

Atrial fibrillation is an important and independent risk factor for cerebrovascular disease and vascular dementia. There is increasing evidence that atrial fibrillation is associated with an increased risk of asymptomatic or silent cerebral infarction and as a result may confer an increased risk of progressive cognitive impairment on a person. In this study we sought to determine whether this hypothesis could be explored in a prospective case controlled design. Twenty seven patients with non-valvular atrial fibrillation (NVAF) and no history of stroke, transient ischaemic attack, dementia, and thyrotoxicosis were compared with 54 age and sex matched controls in sinus rhythm. All cases underwent clinical examination, ECG, and psychological assessment using a battery of nine neuropsychological tests. Between group analysis and a comparison of mean test scores of paired controls with cases were undertaken. The presence of atrial fibrillation was consistently associated with poorer performances on all the subtests of the neuropsychological battery. There was no association between duration of atrial fibrillation and performance. These results provide evidence to justify further examination of the hypothesis in a larger prospective study to determine whether antithrombotic therapy may protect against cognitive decline in patients at maximal risk of silent cerebral ischaemia and associated cognitive decline.

Entities:  

Mesh:

Year:  1998        PMID: 9728958      PMCID: PMC2170228          DOI: 10.1136/jnnp.65.3.386

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Alteration of cerebrovascular haemodynamic patterns due to atrial fibrillation: an in silico investigation.

Authors:  S Scarsoglio; A Saglietto; M Anselmino; F Gaita; L Ridolfi
Journal:  J R Soc Interface       Date:  2017-04       Impact factor: 4.118

2.  Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Authors:  Arvind Nishtala; Ryan J Piers; Jayandra J Himali; Alexa S Beiser; Kendra L Davis-Plourde; Jane S Saczynski; David D McManus; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2017-09-22       Impact factor: 6.343

3.  Executive dysfunction in subcortical ischaemic vascular disease.

Authors:  J H Kramer; B R Reed; D Mungas; M W Weiner; H C Chui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

4.  Absence of an impact of emotional distress on the perception of intracardiac shock discharges.

Authors:  Karl-Heinz Ladwig; Birgitt Marten-Mittag; Günter Lehmann; Harald Gündel; Heidi Simon; Eckhard Alt
Journal:  Int J Behav Med       Date:  2003

5.  Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors.

Authors:  C Lefebvre; D Deplanque; E Touzé; H Hénon; L Parnetti; F Pasquier; V Gallai; D Leys
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 4.849

6.  Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad
Journal:  Pacing Clin Electrophysiol       Date:  2014-12-10       Impact factor: 1.976

7.  Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.

Authors:  Hrafnhildur Stefansdottir; David O Arnar; Thor Aspelund; Sigurdur Sigurdsson; Maria K Jonsdottir; Haukur Hjaltason; Lenore J Launer; Vilmundur Gudnason
Journal:  Stroke       Date:  2013-02-26       Impact factor: 7.914

8.  Atrial fibrillation and cognitive decline: a longitudinal cohort study.

Authors:  Evan L Thacker; Barbara McKnight; Bruce M Psaty; W T Longstreth; Colleen M Sitlani; Sascha Dublin; Alice M Arnold; Annette L Fitzpatrick; Rebecca F Gottesman; Susan R Heckbert
Journal:  Neurology       Date:  2013-06-05       Impact factor: 9.910

9.  Atrial fibrillation, cognitive impairment, and neuroimaging.

Authors:  Jonathan Graff-Radford; Malini Madhavan; Prashanthi Vemuri; Alejandro A Rabinstein; Ruth H Cha; Michelle M Mielke; Kejal Kantarci; Val Lowe; Matthew L Senjem; Jeffrey L Gunter; David S Knopman; Ronald C Petersen; Clifford R Jack; Rosebud O Roberts
Journal:  Alzheimers Dement       Date:  2015-10-23       Impact factor: 21.566

10.  Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.

Authors:  Knut Tore Lappegård; Monica Pop-Purceleanu; Waander van Heerde; Joe Sexton; Indira Tendolkar; Gheorghe Pop
Journal:  J Neuroinflammation       Date:  2013-06-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.